Lansoprazole Capsule, Delayed Release Pellets
Product Images NDC 48433-051

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 48433-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Structural Formula (Image 01)

Chemical structure of lansoprazole depicted as a two-dimensional molecular diagram showing the arrangement of atoms and bonds, including aromatic rings, sulfoxide, and trifluoromethoxy functional groups.*

FDA Label Image

Figure 1. (Image 02)

A line graph showing mean severity of day heartburn over days from the start of treatment in evaluable patients. It compares placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily groups, with severity ratings from 0 (none) to 3 (severe). Lansoprazole groups show reduced heartburn severity compared to placebo over about 60 days.*

FDA Label Image

Figure 2. (Image 03)

A line graph depicting the mean severity of night heartburn over days from the start of treatment for evaluable patients. It compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, showing severity scores on the y-axis and days on the x-axis.*

FDA Label Image

Lansoprazole Delayed-release 30 mg Capsules, Usp Unit Carton Label (Image 04)

Lansoprazole Delayed-Release Capsules USP 30 mg by Safecor Health LLC, presented in an 80 caps (8 x 10) bottle. The label includes dosage strength, capsule image, storage instructions at 20° to 25°C, and manufacturing details by Mylan Pharmaceuticals Inc., Morgantown, WV.*

FDA Label Image

Unit Carton (Image 06)

The image shows the back panel of a Lansoprazole 30 mg delayed-release pellets capsule unit dose package by Safecor Health LLC. It features safety and storage warnings indicating the package is not child-resistant, intended for institutional use, provides light resistance, and advising to keep out of reach of children. Contact information includes a customer service number and SafecorHealth.com.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.